“It is also suggested … and labile forms of Fe or Cu ions, such as non transferrin-bound iron (NTBI) or intracellular low molecular weight …, are among the main factors that may cause variations in the therapeutic response to HU in cancer, sickle cell anemia, … and other groups of patients.”